Antibody Discovery

Identifying antibodies that modulate ion channel function is particularly challenging due to a limited extracellular target area, low immunogenicity and high conservation between orthologs leading to tolerance. TetraGenetics is addressing these challenges by combining TetraExpress™ with antibody platforms that use phylogentically diverse animal hosts and incorporate deep screening to identify rare therapeutically relevant antibodies.